Literature DB >> 22487681

PHF19 and Akt control the switch between proliferative and invasive states in melanoma.

Stephanie Ghislin1, Frederique Deshayes, Sandrine Middendorp, Nicole Boggetto, Catherine Alcaide-Loridan.   

Abstract

Melanoma tumor cells shift between proliferative and invasive states based on their plasticity and microenvironmental conditions. Our team has shown that melanoma cells, grown as spheroids in a neural cell crest medium, polarize toward an invasive phenotype, characterized by a higher motility, a poor proliferation rate and a gain of pluripotency gene expression (Nanog and Oct4) when compared with cells grown in two dimensions in a serum-contaning medium. In agreement with the phenotypic switching hypothesis, most of these features are reversible. Microarray studies comparing two- vs. three-dimensional cultures revealed the downregulation of a polycomb-like protein, PHF19 (PHD finger protein 19), in the spheroids. As Polycomb proteins are involved in the epigenetic control of gene expression, we hypothesized that PHF19 might play a role in the switch between proliferative and invasive phenotypes. In this report, we show that PHF19 silencing reduces the cell proliferation rate and increases the transendothelial migration capacities of melanoma cell lines. However, PHF19 does not modulate the transcription level of Oct4 and Nanog. In the search of an upstream transcriptional regulator of the above genes, we identified the Akt signaling cascade as an inhibitor of Oct4 and Nanog expression and an activator for PHF19 expression. Through chromatin immunoprecipitation, we further provide evidence that phospho-Akt is part of the transcriptional complex associated to the promoters of all three genes. Our data therefore indicate the role of PHF19 and its upstream regulator, Akt, in the phenotype switch of melanoma cells from proliferative to invasive states.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22487681     DOI: 10.4161/cc.20095

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  21 in total

Review 1.  Polycomb Group (PcG) Proteins and Human Cancers: Multifaceted Functions and Therapeutic Implications.

Authors:  Wei Wang; Jiang-Jiang Qin; Sukesh Voruganti; Subhasree Nag; Jianwei Zhou; Ruiwen Zhang
Journal:  Med Res Rev       Date:  2015-07-30       Impact factor: 12.944

2.  Hypoxia induces phenotypic plasticity and therapy resistance in melanoma via the tyrosine kinase receptors ROR1 and ROR2.

Authors:  Michael P O'Connell; Katie Marchbank; Marie R Webster; Alexander A Valiga; Amanpreet Kaur; Adina Vultur; Ling Li; Meenhard Herlyn; Jessie Villanueva; Qin Liu; Xiangfan Yin; Sandy Widura; Janelle Nelson; Nivia Ruiz; Tura C Camilli; Fred E Indig; Keith T Flaherty; Jennifer A Wargo; Dennie T Frederick; Zachary A Cooper; Suresh Nair; Ravi K Amaravadi; Lynn M Schuchter; Giorgos C Karakousis; Wei Xu; Xiaowei Xu; Ashani T Weeraratna
Journal:  Cancer Discov       Date:  2013-10-08       Impact factor: 39.397

3.  Low intensity ultrasound promotes the sensitivity of rat brain glioma to Doxorubicin by down-regulating the expressions of p-glucoprotein and multidrug resistance protein 1 in vitro and in vivo.

Authors:  Zhen Zhang; Ke Xu; Yonghua Bi; Guibo Yu; Siwei Wang; Xun Qi; Hongshan Zhong
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

4.  Anti-chondroitin sulfate proteoglycan 4-specific antibodies modify the effects of vemurafenib on melanoma cells differentially in normoxia and hypoxia.

Authors:  Daniela Pucciarelli; Nina Lengger; Martina Takacova; Lucia Csaderova; Maria Bartosova; Heimo Breiteneder; Silvia Pastorekova; Christine Hafner
Journal:  Int J Oncol       Date:  2015-05-18       Impact factor: 5.650

Review 5.  Melanoma cells revive an embryonic transcriptional network to dictate phenotypic heterogeneity.

Authors:  Niels Vandamme; Geert Berx
Journal:  Front Oncol       Date:  2014-12-09       Impact factor: 6.244

6.  G9a orchestrates PCL3 and KDM7A to promote histone H3K27 methylation.

Authors:  Mei-Ren Pan; Ming-Chuan Hsu; Li-Tzong Chen; Wen-Chun Hung
Journal:  Sci Rep       Date:  2015-12-21       Impact factor: 4.379

7.  PHF19 promotes the proliferation, migration, and chemosensitivity of glioblastoma to doxorubicin through modulation of the SIAH1/β-catenin axis.

Authors:  Qing Deng; Jianbing Hou; Liying Feng; Ailing Lv; Xiaoxue Ke; Hanghua Liang; Feng Wang; Kui Zhang; Kuijun Chen; Hongjuan Cui
Journal:  Cell Death Dis       Date:  2018-10-15       Impact factor: 8.469

8.  High PHD Finger Protein 19 (PHF19) expression predicts poor prognosis in colorectal cancer: a retrospective study.

Authors:  Pengfei Li; Jie Sun; Yuanyuan Ruan; Lujun Song
Journal:  PeerJ       Date:  2021-06-01       Impact factor: 2.984

9.  Impaired DICER1 function promotes stemness and metastasis in colon cancer.

Authors:  M S Iliou; V da Silva-Diz; F J Carmona; J Ramalho-Carvalho; H Heyn; A Villanueva; P Muñoz; M Esteller
Journal:  Oncogene       Date:  2013-10-07       Impact factor: 9.867

10.  BMI1 induces an invasive signature in melanoma that promotes metastasis and chemoresistance.

Authors:  Roberta Ferretti; Arjun Bhutkar; Molly C McNamara; Jacqueline A Lees
Journal:  Genes Dev       Date:  2015-12-17       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.